Birdwatch Note Rating
2024-11-29 23:12:53 UTC - HELPFUL
Rated by Participant: FA415D61CD49C6CFC6DA7A65E920E591022315BD2CB9EB70C08587CAAE3BC601
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details